Advertisement

Topics

Oral insulin therapy fails to prevent type 1 diabetes, but some see disease delay

09:01 EDT 15 Jun 2017 | Healio

SAN DIEGO — In adults with two or more antibodies predicting the development of type 1 diabetes, treatment with daily oral insulin therapy did not prevent development of the disease, but a small subset experienced a 31-month delay in clinical diabetes development, according to a speaker here. “It’s important to note, this [delay in disease development] was not the primary endpoint, nor the primary group, so overall, the [trial] results were negative,” Carla J. Greenbaum, MD, of the Benaroya Research Institute in Seattle, said during a press conference announcing the findings. “Nonetheless, this dramatic result in the secondary analysis remains something we wish to follow up on.”

Original Article: Oral insulin therapy fails to prevent type 1 diabetes, but some see disease delay

NEXT ARTICLE

More From BioPortfolio on "Oral insulin therapy fails to prevent type 1 diabetes, but some see disease delay"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...